ATE451475T1 - Verfahren und systeme zur diagnose von nicht das zentrale nervensystem (zns) betreffenden krankheiten in zns-proben - Google Patents

Verfahren und systeme zur diagnose von nicht das zentrale nervensystem (zns) betreffenden krankheiten in zns-proben

Info

Publication number
ATE451475T1
ATE451475T1 AT04777581T AT04777581T ATE451475T1 AT E451475 T1 ATE451475 T1 AT E451475T1 AT 04777581 T AT04777581 T AT 04777581T AT 04777581 T AT04777581 T AT 04777581T AT E451475 T1 ATE451475 T1 AT E451475T1
Authority
AT
Austria
Prior art keywords
cns
systems
nervous system
central nervous
samples
Prior art date
Application number
AT04777581T
Other languages
English (en)
Inventor
Osvaldo Podhajcer
Fernando Pitossi
Marcelo Rubinstein
Original Assignee
Gentron Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gentron Llc filed Critical Gentron Llc
Application granted granted Critical
Publication of ATE451475T1 publication Critical patent/ATE451475T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57423—Specifically defined cancers of lung
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
AT04777581T 2003-07-03 2004-07-02 Verfahren und systeme zur diagnose von nicht das zentrale nervensystem (zns) betreffenden krankheiten in zns-proben ATE451475T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US48472603P 2003-07-03 2003-07-03
US48468303P 2003-07-03 2003-07-03
PCT/US2004/021543 WO2005007892A1 (en) 2003-07-03 2004-07-02 Methods and systems for diagnosis of non-cenral nervous system (cns) diseases in cns samples

Publications (1)

Publication Number Publication Date
ATE451475T1 true ATE451475T1 (de) 2009-12-15

Family

ID=34083317

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04777581T ATE451475T1 (de) 2003-07-03 2004-07-02 Verfahren und systeme zur diagnose von nicht das zentrale nervensystem (zns) betreffenden krankheiten in zns-proben

Country Status (8)

Country Link
US (2) US20060263783A1 (de)
EP (1) EP1649062B1 (de)
JP (1) JP2007531494A (de)
AT (1) ATE451475T1 (de)
AU (1) AU2004258101B2 (de)
CA (1) CA2531281A1 (de)
DE (1) DE602004024539D1 (de)
WO (1) WO2005007892A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007359085A1 (en) * 2006-11-16 2009-03-26 Gentron, Llc Methods, systems, and compositions for cancer diagnosis
EP2167633A4 (de) * 2007-07-16 2014-12-24 California Inst Of Techn Mikrofluidische vorrichtungen, verfahren und systeme zur erkennung von zielmolekülen
US8252540B2 (en) 2007-08-03 2012-08-28 Keio University Drug delivery system toward demyelinating lesion and biochemical marker of demyelinating lesion
WO2009051238A1 (ja) 2007-10-18 2009-04-23 Riken ヒト白血病幹細胞および白血病非幹細胞が増幅されたマウスおよびその製造方法
WO2010030293A1 (en) * 2008-09-15 2010-03-18 Gentron, Inc. Methods, systems, and compositions for cancer diagnosis
WO2010075249A2 (en) 2008-12-22 2010-07-01 Genentech, Inc. A method for treating rheumatoid arthritis with b-cell antagonists
JP2011149859A (ja) * 2010-01-22 2011-08-04 Igaku Seibutsugaku Kenkyusho:Kk 食道癌マーカー
US20130151197A1 (en) * 2011-11-23 2013-06-13 General Electric Company Automated performance measurement processes and systems
US8912159B2 (en) * 2012-02-24 2014-12-16 National Institutes Of Health (Nih) Analyzing semaphorin7a (Sema7A) levels for assessing cancer metastatic potential and methods of treatment
CN108267581A (zh) 2012-08-24 2018-07-10 耶鲁大学 用于高通量多重检测的系统、装置和方法
EP3227684B1 (de) 2014-12-03 2019-10-02 Isoplexis Corporation Analyse und screening für die sekretionprofile von zellen
US11353448B2 (en) 2015-02-13 2022-06-07 California Institute Of Technology Methods and compositions for quantifying metabolites and proteins from single cells
EP3262190B1 (de) * 2015-02-24 2021-09-01 Ruprecht-Karls-Universität Heidelberg Biomarkeranordnung für den nachweis von krebs
CN110199196B (zh) 2016-11-11 2022-09-30 伊索普莱克西斯公司 用于单细胞的同时基因组，转录本和蛋白质组分析的组合物和方法
US11525783B2 (en) 2016-11-22 2022-12-13 IsoPlexis Corporation Systems, devices and methods for cell capture and methods of manufacture thereof
KR102207697B1 (ko) * 2019-06-24 2021-01-26 재단법인 대구경북첨단의료산업진흥재단 뇌미세혈관 손상 뇌질환 진단용 바이오 마커 조성물
KR20210000253A (ko) * 2019-12-16 2021-01-04 재단법인 대구경북첨단의료산업진흥재단 뇌미세혈관 손상 뇌질환 진단용 바이오 마커 조성물
KR102207696B1 (ko) * 2019-06-24 2021-01-26 재단법인 대구경북첨단의료산업진흥재단 뇌미세혈관 손상 뇌질환 진단용 바이오 마커 조성물
KR102207699B1 (ko) * 2019-06-24 2021-01-26 재단법인 대구경북첨단의료산업진흥재단 뇌미세혈관 손상 뇌질환 진단용 바이오 마커 조성물
KR102207698B1 (ko) * 2019-06-24 2021-01-26 재단법인 대구경북첨단의료산업진흥재단 뇌미세혈관 손상 뇌질환 진단용 바이오 마커 조성물
KR20210000255A (ko) * 2019-12-16 2021-01-04 재단법인 대구경북첨단의료산업진흥재단 뇌미세혈관 손상 뇌질환 진단용 바이오 마커 조성물
KR102100588B1 (ko) * 2019-06-24 2020-04-13 재단법인 대구경북첨단의료산업진흥재단 뇌미세혈관 손상 뇌질환 진단용 바이오 마커 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7676894A (en) * 1993-08-27 1995-03-21 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Convection-enhanced drug delivery
US6921658B1 (en) * 1998-11-20 2005-07-26 Fuso Pharmacutical Industries, Ltd. Serine protease BSSP6
WO2000050889A1 (en) * 1999-02-23 2000-08-31 Warner-Lambert Company System and method for managing and presenting information derived from gene expression profiling
AU773329B2 (en) * 1999-05-14 2004-05-20 Proteomedica Ab Materials and methods relating to disease diagnosis
DE60140865D1 (de) * 2000-03-27 2010-02-04 Univ Jefferson Zusammensetzungen und methoden zur identifizierung von krebszellen
US6372250B1 (en) * 2000-04-25 2002-04-16 The Regents Of The University Of California Non-invasive gene targeting to the brain
WO2002024956A2 (en) * 2000-09-19 2002-03-28 Whitehead Institute For Biomedical Research Genetic markers for tumors
CN1526025A (zh) * 2001-05-16 2004-09-01 ��˹��ŵ�� 作为预后和治疗靶标的乳腺癌中表达的基因
EP1451340B1 (de) * 2001-11-09 2014-01-08 Life Technologies Corporation Identifizierung, überwachung und behandlung einer krankheit sowie charakterisierung eines biologischen zustands unter verwendung von genexpressionsprofilen

Also Published As

Publication number Publication date
US20060263783A1 (en) 2006-11-23
WO2005007892A1 (en) 2005-01-27
JP2007531494A (ja) 2007-11-08
US20110251077A1 (en) 2011-10-13
CA2531281A1 (en) 2005-01-27
EP1649062A1 (de) 2006-04-26
EP1649062B1 (de) 2009-12-09
AU2004258101A1 (en) 2005-01-27
AU2004258101B2 (en) 2010-12-23
DE602004024539D1 (de) 2010-01-21

Similar Documents

Publication Publication Date Title
ATE451475T1 (de) Verfahren und systeme zur diagnose von nicht das zentrale nervensystem (zns) betreffenden krankheiten in zns-proben
ATE440536T1 (de) Verfahren zur diagnose, behandlung und prävention von knochenverlust
PL2341344T3 (pl) Sposób diagnozowania wielotorbielowatości nerek
DK1421215T3 (da) Fremgangsmåder til evaluering af patologiske tilstande under anvendelse af ekstracellulært RNA
WO2005052592A3 (en) Methods for diagnosis, stratification, and monitoring of alzheimer’s disease
CA3010517A1 (en) Method for evaluating the health status of an individual
GB0514435D0 (en) Diagnostic method for brain damage-related disorders
IL172488A0 (en) Diagnostic methods for monitoring immunologic, hematologic and inflammatory diseases
WO2008148072A3 (en) Disease-associated genetic variations and methods for obtaining and using same
WO2007033216A3 (en) Methods and compositions for the treatment and diagnosis of diseases characterized by vascular leak, hypotension, or a procoagulant state
WO2008063369A3 (en) Biomarkers for neurological conditions
NO20070949L (no) Transkriptomdiagnostikk i spytt
WO2007032876A3 (en) Biomarkers associated with age-related macular degeneration
EA200600920A1 (ru) Иммуносорбентные исследования крови для оценки пароксизмальных церебральных разрядов
WO2007015113A3 (en) New protein isoforms of the pif-family and uses thereof
WO2006121912A3 (en) Diagnostic methods for the detection of risk of neurodevelopmental disorders
WO2007080597A3 (en) Polynucleotide and polypeptide sequences and methods for diagnosis
ATE511651T1 (de) Transglutaminase 6 als diagnostischer indikator für autoimmunerkrankungen
WO2006074450A3 (en) Methods and compositions for detecting and modulating periodontal disorders and periodontal diseases
WO2006002240A3 (en) Computer systems and methods for constructing biological classifiers and uses thereof
WO2004045376A3 (en) Screening methods to identify treatments for autoimmune disease
BRPI0414365A (pt) composições, reagentes e kits para, e métodos de diagnosticar, monitorar e tratar obesidade e/ou diabetes
WO2010033951A3 (en) Methods for identification and prediction of multiple sclerosis disease and therapy response
EP3045173A3 (de) Molekularer genetischer ansatz zur behandlung und diagnose von alkohol- und drogenabhängigkeit
WO2008008487A3 (en) Gene expression profiling for identification, monitoring and treatment of multiple sclerosis

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties